| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/05/2009 | US7528161 NF-kappaB inhibitors and uses thereof |
| 05/05/2009 | US7528143 JAK family of protein tyrosine kinases inhibitors; N4-(4-Methoxy-phenyl)-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine; angiogenic-associated disorders including solid tumors and cancer, eye disease, inflammation, psoriasis, viral infection; antiproliferative agents |
| 05/05/2009 | US7528142 Aminopyrimidines useful as kinase inhibitors |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528132 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; indazolyl [1,2,4]triazine compounds |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7528121 Aurora kinases inhibitors; antiproliferative agents; specially for solid and haematological tumors; 2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 04/30/2009 | WO2009055721A2 5-lipoxygenase activating protein (flap) inhibitor |
| 04/30/2009 | WO2009055548A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/30/2009 | WO2009055357A1 Diazepane compounds which modulate the cb2 receptor |
| 04/30/2009 | WO2009055335A2 Hcv protease inhibitors |
| 04/30/2009 | WO2009054864A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | WO2009054791A1 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054790A1 Amide linked heteroaromatic derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054789A1 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054785A1 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009053993A2 Process for preparation of novel salt of voriconazole oxalate form-c |
| 04/30/2009 | WO2009053694A1 Therapeutic oxy-phenyl-aryl compounds and their use |
| 04/30/2009 | WO2009053459A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators |
| 04/30/2009 | WO2009053269A1 Novel kinase inhibitors |
| 04/30/2009 | WO2009010429A3 Novel heterocyclyl compounds and their use as chemokine antagonists |
| 04/30/2009 | WO2009004164A3 Diazeniumdiolate derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2008140553A4 Mapk/erk kinase inhibitors |
| 04/30/2009 | WO2007119246A3 An improved process for the manufacture of losartan potassium |
| 04/30/2009 | WO2007056220A3 5-lipoxygenase-activating protein (flap) inhibitors |
| 04/30/2009 | WO2007001818A3 Substituted isoindole-1,3-diones |
| 04/30/2009 | US20090111996 N-(2-aminophenyl)-4-((5,6-dimethoxy-2H-indazol-2-yl)methyl)benzamide, as a solid or liquid formulation adapted for oral administration; antiprolilferative agent |
| 04/30/2009 | US20090111982 Macrocyclic compounds as inhibitors of viral replication |
| 04/30/2009 | US20090111867 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 04/30/2009 | US20090111864 N-methyl-4-{4-[7-(4-cyano-3 -trifluoromethylphenyl)-6,8-dioxo-5,7-diazaspiro[3.4]oct-5-yl]-phenyl}butyramide; for treatment of hormone refractory prostate cancer |
| 04/30/2009 | US20090111832 Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 04/30/2009 | US20090111827 ARYLINDENOPYRIMIDINES COMPOUND AND USE AS AN ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 04/30/2009 | US20090111825 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111824 Amide linked heteroaromatic derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111823 Aminopyridine derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111822 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111821 Amino 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111819 New pyridazin-3(2h)-one derivatives |
| 04/30/2009 | US20090111804 ARYLINDENOPYRIMIDINES AND THEIR USE AS ADENOSINE A2a |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | US20090111800 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111799 Anti-infective agents against intracellular pathogens |
| 04/30/2009 | US20090111796 7-membered ring compound and method of production and pharmaceutical application thereof |
| 04/30/2009 | US20090111795 Multimers of Heterocyclic Compounds and Their Use |
| 04/30/2009 | US20090111791 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same |
| 04/30/2009 | US20090111789 Chiral cis-imidazolines |
| 04/30/2009 | US20090111731 Novel topical application agents against mimic and age-related wrinkles |
| 04/30/2009 | CA2704052A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | CA2702798A1 5-lipoxygenase activating protein (flap) inhibitor |
| 04/30/2009 | CA2702772A1 Diazepane compounds which modulate the cb2 receptor |
| 04/30/2009 | CA2701275A1 Novel kinase inhibitors |
| 04/29/2009 | EP2052033A1 Squarylium compound, optical recording medium using the same, recording/reproduction method and optical recording apparatus |
| 04/29/2009 | EP2051978A2 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/29/2009 | EP2051977A2 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1 |
| 04/29/2009 | CN101421252A 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin D2 receptor antagonists |
| 04/29/2009 | CN101421250A 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 04/29/2009 | CN101421234A Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN101420957A Therapeutic agent for inflammatory bowel disease |
| 04/29/2009 | CN101417997A Inhibitor compounds containing benzo2-aminoimidazloe skeleton and preparation method thereof |
| 04/29/2009 | CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/29/2009 | CN100482648C New uracils having a herbicidal activity |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524955 Process for the preparation of pyrimidine compounds |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524867 Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity |
| 04/28/2009 | US7524849 5-arylpyrimidines as anticancer agents |
| 04/28/2009 | US7524848 Diaza heterocyclic amide compounds and their uses |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | US7524841 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 04/28/2009 | US7524839 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 04/28/2009 | US7524838 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 04/28/2009 | US7524837 Benzotriazapinone salts and methods for using same |
| 04/28/2009 | CA2525437C Benzamide inhibitors of the p2x7 receptor |
| 04/28/2009 | CA2400176C Substituted piperazine compounds |
| 04/28/2009 | CA2395407C Method for producing 4-(heteroaryl-methyl)-1(2h)-phthalazinones |
| 04/28/2009 | CA2375259C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/28/2009 | CA2273328C 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 04/28/2009 | CA2227762C Substituted aminouracils |
| 04/23/2009 | WO2009052068A1 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof |
| 04/23/2009 | WO2009052065A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009052063A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 04/23/2009 | WO2009052062A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009051556A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs) |
| 04/23/2009 | WO2009051504A1 Benzo- and pyridopyridazinones with analgesic and antiinflammatory activity |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051216A1 Process for stereoselective production of optically active pyrrolyl-succinic acid imide derivative |
| 04/23/2009 | WO2009051112A1 Amide compounds and use of the same |
| 04/23/2009 | WO2009050999A1 Indolium compound and optical recording material using the compound |
| 04/23/2009 | WO2009050243A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050227A1 Pyridazine derivatives for inhibiting beta amyloid peptide production |
| 04/23/2009 | WO2009050220A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050218A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050200A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 04/23/2009 | WO2009049495A1 Crystalline imidazol-5-carboxylic acid derivate |
| 04/23/2009 | WO2009024342A3 Novel microbiocides |
| 04/23/2009 | WO2009013211A3 New pyrazol derivatives |
| 04/23/2009 | WO2009004383A3 Aza-bicyclohexane compounds useful as anticoagulants |